Optival Health Solutions, a subsidiary of MedPlus Health Services, faces a seven-day suspension of its Drug License for a store in Karnataka due to violations under the Drugs and Cosmetics Act. This order, received recently, could lead to a potential revenue loss of approximately ₹1.36 lakhs (1.36 Cr). The impact on MedPlus Health Services' operations may warrant close monitoring, considering the implications of regulatory compliance and potential business interruptions. Investors should watch closely for any updates regarding the situation and the company's strategies to mitigate any adverse effects.